FOXO1 Rabbit Polyclonal Antibody
CAT#: TA323072
Anti-FOXO1 (Phospho-Ser256) Rabbit Polyclonal Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CNY 3,800.00
Cited in 7 publications. |
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | IF, IHC, WB |
Recommend Dilution | WB: 500-2000 WB positive control: Hela cell lysate IHC: 25-100 Positive control: Human ovarian cancer Predicted cell location: Cytoplasm and Nucleus |
Reactivity | Human, Mouse, Rat |
Modifications | Phospho-specific |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Peptide sequence around phosphorylation site of serine 256 (A-A-S(p)-M-D) derived from Human FKHR. |
Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 70 kDa |
Gene Name | forkhead box O1 |
Database Link | |
Background | This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. |
Synonyms | FKH1; FKHR; FOXO1A |
Reference Data | |
Protein Families | Druggable Genome, Transcription Factors |
Protein Pathways | Insulin signaling pathway, Pathways in cancer, Prostate cancer |
Citations (7)
The use of this Antibodies has been cited in the following citations: |
---|
Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation
,Ge, C;Xu, M;Qin, Y;Gu, T;Lou, D;Li, Q;Hu, L;Nie, X;Wang, M;Tan, J;,
Food Funct
,PubMed ID 31074472
[FOXO1]
|
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
,Ji, YX;Huang, Z;Yang, X;Wang, X;Zhao, LP;Wang, PX;Zhang, XJ;Alves-Bezerra, M;Cai, L;Zhang, P;Lu, YX;Bai, L;Gao, MM;Zhao, H;Tian, S;Wang, Y;Huang, ZX;Zhu, XY;Zhang, Y;Gong, J;She, ZG;Li, F;Cohen, DE;Li, H;,
Nat. Med.
,PubMed ID 29291351
[FOXO1]
|
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
,Zhang, P;Wang, PX;Zhao, LP;Zhang, X;Ji, YX;Zhang, XJ;Fang, C;Lu, YX;Yang, X;Gao, MM;Zhang, Y;Tian, S;Zhu, XY;Gong, J;Ma, XL;Li, F;Wang, Z;Huang, Z;She, ZG;Li, H;,
Nat. Med.
,PubMed ID 29227477
[FOXO1]
|
Inhibition of Miro1 disturbs mitophagy and pancreatic β-cell function interfering insulin release via IRS-Akt-Foxo1 in diabetes
,Chen, L;Liu, C;Gao, J;Xie, Z;Chan, LWC;Keating, DJ;Yang, Y;Sun, J;Zhou, F;Wei, Y;Men, X;Yang, S;,
Oncotarget
,PubMed ID 29207597
[FOXO1]
|
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.
,null,
Nature medicine
,PubMed ID 28218919
[FOXO1]
|
The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance
,Zhang, QY;Zhao, LP;Tian, XX;Yan, CH;Li, Y;Liu, YX;Wang, PX;Zhang, XJ;Han, YL;,
Hepatology
,PubMed ID 28508477
[FOXO1]
|
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
,null,
Nature Communications
,PubMed ID 26882989
[FOXO1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |